DIFFICULTIES OF DIFFERENTIAL DIAGNOSTICS OF MESADENITES IN HIV-INFECTION PATIENTS
https://doi.org/10.22625/2072-6732-2018-10-3-61-69
Abstract
The development of mesenteric lymphadenitis is typical for patients with HIV infection at the stage of secondary diseases. The purpose of our study is to decipher the etiology of lymphadenitis in patients with HIV infection at the stage of secondary diseases. The analysis of disease histories of 113 HIV infection patients at the stage of secondary diseases with the use of statistical processing was carried out. The article presents examples that characterize the polymorphism of clinical variants of the development of mesadenitis in HIVinfected patients with stage 4B, which has developed as a result of the influence of various etiological factors.
About the Authors
D. D. Arutyunova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
K. T. Umbetova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
Yu. G. Parchomenko
Infectious Clinical Hospital № 2
Russian Federation
Moscow
Russian Federation
Moscow
O. A. Tishkevich
Infectious Clinical Hospital № 2
Russian Federation
Moscow
Russian Federation
Moscow
E. V. Volchkova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
S. G. Pak
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
References
1. http://www.who.int/features/qa/71/ru/; Informacionnyj byulleten’, Mart 2017g. http://www.who.int/mediacentre/factsheets/fs104/ru/
2. Murray J, Sonnenberg P, Nelson G, Bester A, Shearer S, Glynn J R. Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. AIDS 2007; 21 (Suppl 6): p.97-104.
3. Frolova O.P., Yakubova V.A. Organization of phthisiatric care for people with HIV infection // Problemy tuberkuleza. 2005. - №6. 16-20s. (in Russian)
4. Kravchenko A.B., SHahgil’dyan V.I., YUrin O.G., i dr. // Tuberculosis in patients with HIV infection // Ter. Arhiv. 1996. - T.68, №4. 69-71s.
5. Zimina V.N., Koshechkin V.A, Kravchenko A.V. Tuberkulez i VICH-infekciya u vzroslyh. M. : GEHOTAR- Media, 2014. 224s.
6. Features of the clinical course of generalized tuberculosis depending on the patient’s HIV status / M.O. Majorova i dr. // Tuberkulez i bolezni legkih. 2011. - №5. - S.36-37.
7. Parhomenko YU.G., Erohin V.V., Zyuzya YU.R., Mazus A.I. Morfologicheskie aspekty VICH-infekcii. M. Izd. «Litera», 2016, 162 s.
8. Schelkanova A.I. Features of the clinical course and effectiveness of chemotherapy for tuberculosis in HIV-infected individuals: Avtoref. dis. kand. med. nauk. M., 2003. 24 s.
9. Pokrovskij V.V. VICH-infekciya i SPID. Klinicheskie rekomendacii. M.: GEHOTAR - Medic. - 2006. - 128 s.
10. G.F. Moshkovich i dr. // Evaluation of the effectiveness of various HAART regimens in patients with HIV infection and tuberculosis// Problemy tuberkuleza u bol’nyh VICH-infekciej. Byulleten’ № 7. M., 2009. 77-78s.
11. Puzyryova L.V., Safonov A.D., Mordyk A.V. Diseases of the respiratory system in HIV infection (review). Zhurnal infektologii. 2016, Tom 8, №2. 17-25s.
12. KohDM, Burn PR, Mathews G, Nelson M, Healy JC. Abdominal computed tomographic findings of Mycobacterium tuberculosis and Mycobacterium avium intracellulare infection in HIV seropositive patients. Can. Assoc. Radiol. 2003; 54: р.45–50.
13. Cole T., Kewman D., Boninger M. Development of medical rehabilitation research in 20th-century America//Am J Phys Med Rehabil. 2005. -v. 84(12). - p.940-54.
14. Makarova M.V. Isolation and identification of nontuberculous mycobacteria in patients with TB facilities: dissertaciya doktora biologicheskih nauk, Moskva, 2010. 237s.
15. Cinzerling V.A, Svistunov V.V., Karev V.E, Semenova N.YU. Morphological diagnosis of tuberculosis in modern conditions. Arhiv patologii, №3, 2015. 3-9s.
16. Silverberg M.J., Chao Ch., Leyden W.A., Xu L., Horberg M.A., Klein D. et al. HIV infection, Immunodeficiency, Viral Replication and the Risk of Cancer. Cancer Epidemiol. Biomarkers Prev. 2011; 20 (12): 2551–9.
17. Mel’nikova E.L., Volchkova E.V., Ivannikov E.V., Ol’shanskij A.YA., Vdovina V.N., Parhomenko YU.G. Risk factors for non-Hodgkin’s lymphoma in patients with HIV coinfection and viral hepatitis C. Epidemiologiya i infekcionnye bolezni. 2013, №5, 4-8s.
18. Muhammad A Mir, MD, FACP; Chief Editor: Emmanuel C Besa, MD. AIDS-Related Lymphomas. Medscape, Drugs & Diseases, Hematology, Dec 01, 2015. http://emedicine.medscape.com/article/1389907-overview
19. Dzhon Bartlett, Dzhoehl Gallant, Pol Fam. Klinicheskie aspekty VICH-infekcii, 2009-2010. 451s.
20. Poddubnoj I.V., Savchenko V.G. Rossijskie klinicheskie rekomendacii po diagnostike i lecheniyu limfoproliferativnyh zabolevanij. 2016. 158s.
21. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin’s lymphoma. Hematol. Oncol. Clin. North Am. 2003. Jun. 17(3): р.785-820.
22. Kirk O, Pedersen C, Cozzi-Lepri A, et al, for the EuroSIDA Study Group. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.Blood. 2001 Dec 1. 98(12): р.3406-12.
23. Powles T, Matthews G, Bower M. AIDS related systemic non-Hodgkin’s lymphoma. Sex Transm. Infect. 2000 Oct. 76(5): р.335-41.
24. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 2003. Jan;4(1): р.22–9.
25. A Review of Human Carcinogens, Part B: Biological Agents. р.215-217. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: World Health Organization International Agency for Reseach on Cancer; 2012. ISBN13 9789283213291 http://monographs.iarc.fr/ENG/Monographs/vol100B /mono100B-10.pdf
26. Besson C, Goubar A, Gabarre J, et al. (October 2001). «Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy». Blood. 98 (8): 2339–44.
27. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM: AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J. Clin. Oncol. 2005. 23, р.4430–4438.
28. Standart medicinskoj pomoshchi bol’nym bolezn’yu, vyzvannoj virusom immunodeficita cheloveka (VICH) pri okazanii specializirovannoj pomoshchi: Utv. prikazom Ministerstva zdravoohraneniya i social’nogo razvitiya Rossijskoj Federacii ot 9 iyulya 2007 g. № 475.
29. Panteleev A. M. Pathogenesis, clinic, diagnosis and treatment of tuberculosis in patients with HIV infection: Avtoreferat dissertacii «Patogenez, klinika, diagnostika i lechenie tuberkuleza u bol’nyh VICH-infekciej» doktora medicinskih nauk: 14.01.16, Sankt-Peterburg, 2012. 214 s.
30. Zagdyn Z.M., Kotlyar V.L., Suhanova YU.V., Cinzerling V.A., Kovelenov A.YU, Oyuuntumur G., Vendi Vobesser. Lymph node biopsy can accelerate the detection of tuberculosis in patients with HIV infection. VICH-infekciya i immunosupressii. 2013, t.5, №2, 84-90 s.
Review
For citations:
Arutyunova D.D., Umbetova K.T., Parchomenko Yu.G., Tishkevich O.A., Volchkova E.V., Pak S.G. DIFFICULTIES OF DIFFERENTIAL DIAGNOSTICS OF MESADENITES IN HIV-INFECTION PATIENTS. Journal Infectology. 2018;10(3):61-69. (In Russ.) https://doi.org/10.22625/2072-6732-2018-10-3-61-69
Views:
887
.png)
.png)
Email this article 